Case Study: Clinically Relevant NASH Animal Model

Case Study: Clinically Relevant NASH Animal Model - WuXi Biology

Access Resources

Thank you for your interest in our resources. Please fill out the information here to have full access to our library of useful information, including what you are looking for currently.

Name(Required)

Work Email(Required)

Company(Required)

Your Region(Required)

Your Country

U.S. State

European Country

This field is hidden when viewing the form

Your Country

This field is hidden when viewing the form

U.S. State

This field is hidden when viewing the form

Territory

← Return to Resources

Related Content

PD-1 Blockade with a DLL3 TCE Potentiates Efficacy in SCLC

Small cell lung cancer (SCLC) remains one of the most aggressive and difficult-to-treat cancers, highlighting the ongoing need for new...

VIEW RESOURCE

Unveiling Mechanisms of MRTX1133 Resistance

Recent years have seen major advances in KRAS G12D-targeted therapeutics. However, acquired drug resistance remains a significant clinical challenge, with...

VIEW RESOURCE

← View all in vivo Pharmacology Resources

×

Access Resources

Related Content

PD-1 Blockade with a DLL3 TCE Potentiates Efficacy in SCLC

Unveiling Mechanisms of MRTX1133 Resistance

Contact An Expert Today!